MolDX: Targeted and Comprehensive Genomic Profile Next-Generation Sequencing Testing in Cancer - R3

The MolDX: Targeted and Comprehensive Genomic Profile Next-Generation Sequencing Testing in Cancer coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI) and 01312 (NV).

Summary of Changes: HCPCS coding was divided into two paragraphs to provide greater clarity in billing.
Effective Date: May 27, 2019

View the locally hosted MolDX Medicare Coverage Article.

View a complete list of Noridian coverage articles.

  • Go to Noridian Medicare Coverage Articles webpage
  • Scroll to bottom of page
  • Select state/contract link of interest from applicable Active, Future, or Retired Articles column
    • Link will redirect you to CMS MCD
  • In CMS MCD, select corresponding article title to view a comprehensive revision history for this article

Last Updated Jun 11, 2019